As of May 2022 LabCorp has a market cap of $22.95 Billion. This makes LabCorp the world's 753th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $22.67 B | -24.59% |
2021 | $30.06 B | 51.67% |
2020 | $19.82 B | 20.57% |
2019 | $16.44 B | 31.58% |
2018 | $12.49 B | -23.04% |
2017 | $16.23 B | 22.8% |
2016 | $13.22 B | 5.58% |
2015 | $12.52 B | 37.21% |
2014 | $9.12 B | 16.58% |
2013 | $7.83 B | -3.32% |
2012 | $8.09 B | -4.94% |
2011 | $8.51 B | -5.37% |
2010 | $9.00 B | 14.24% |
2009 | $7.88 B | 13.29% |
2008 | $6.95 B | -17.03% |
2007 | $8.38 B | -6.62% |
2006 | $8.97 B | 31.8% |
2005 | $6.81 B | 0.39% |
2004 | $6.78 B | 28.12% |
2003 | $5.29 B | 54.25% |
2002 | $3.43 B | -39.81% |
2001 | $5.70 B |
On May 19th, 2022 the market cap of LabCorp was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() IDEXX Laboratories IDXX | $31.32 B | 36.51% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | $16.64 B | -27.46% | ๐บ๐ธ USA |
![]() Translate Bio
TBIO | $2.82 B | -87.70% | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | $1.12 B | -95.09% | ๐บ๐ธ USA |
![]() Qiagen QGEN | $10.30 B | -55.10% | ๐ณ๐ฑ Netherlands |
![]() Enzo Biochem ENZ | $0.11 B | -99.49% | ๐บ๐ธ USA |